Cubist Systematic Strategies, LLC Blueprint Medicines Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$84.1 - $120.5 $201,840 - $289,200
-2,400 Reduced 26.37%
6,700 $619,000
Q2 2024

Aug 14, 2024
SELL
$85.18 - $108.78 $17,036 - $21,756
-200 Reduced 2.15%
9,100 $980,000
Q1 2024

May 15, 2024
BUY
$73.17 - $99.79 $248,778 - $339,286
3,400 Added 57.63%
9,300 $882,000
Q4 2023

Feb 14, 2024
BUY
$43.96 - $92.84 $259,364 - $547,756
5,900 New
5,900 $544,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.47B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email